- 24/7 Wall St.•2 hours ago
Bristol-Myers Squibb Co. (NYSE: BMY) is scheduled to release third-quarter financial results before markets open on Thursday. The consensus estimates from Thomson Reuters are calling for $0.65 in earnings ...
- Market Realist•8 hours ago
Bristol-Myers Squibb's revenues from Opdivo are estimated to be $938.8 million in 3Q16, as compared to $305 million in 3Q15.
- Zacks•9 hours ago
Bristol-Myers (BMY) could be an interesting stock for investors ahead of earnings, as it has a positive ESP and a favorable Zacks Rank.
Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||49.35 x 100|
|Ask||49.41 x 2800|
|Day's Range||49.07 - 49.76|
|52wk Range||49.03 - 77.12|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||28.82|
|Avg Vol (3m)||14,316,675|
|Dividend & Yield||1.52 (3.09%)|